{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:57:31Z","timestamp":1777784251185,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s1521-6616(02)00017-7","type":"journal-article","created":{"date-parts":[[2003,2,11]],"date-time":"2003-02-11T22:19:26Z","timestamp":1045001966000},"page":"16-22","source":"Crossref","is-referenced-by-count":60,"title":["HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells"],"prefix":"10.1016","volume":"106","author":[{"given":"Marcela V","family":"Maus","sequence":"first","affiliation":[]},{"given":"James L","family":"Riley","sequence":"additional","affiliation":[]},{"given":"William W","family":"Kwok","sequence":"additional","affiliation":[]},{"given":"Gerald T","family":"Nepom","sequence":"additional","affiliation":[]},{"given":"Carl H","family":"June","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1521-6616(02)00017-7_BIB1","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1038\/sj.onc.1204542","article-title":"Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen","volume":"20","author":"Kim","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/hum.1995.6.3-347","article-title":"Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma","volume":"6","author":"Berns","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB3","first-page":"1537","article-title":"Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte\u2013macrophage colony-stimulating factor gene transfer","volume":"57","author":"Simons","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI0214364","article-title":"Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors","volume":"109","author":"Heiser","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1471-4906(00)01813-5","article-title":"Viral vectors for dendritic cell-based immunotherapy","volume":"22","author":"Jenne","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00002371-200007000-00013","article-title":"Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp 100","volume":"23","author":"Panelli","year":"2000","journal-title":"J. Immunother."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.186.8.1213","article-title":"Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases","volume":"186","author":"Specht","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00002371-200107000-00012","article-title":"Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma","volume":"24","author":"Dudley","year":"2001","journal-title":"J. Immunother."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","article-title":"Gene transfer into humans\u2014immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction","volume":"323","author":"Rosenberg","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma","volume":"192","author":"Yee","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm0102-47","article-title":"Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection","volume":"8","author":"Levine","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB13","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1073\/pnas.95.17.10067","article-title":"CTLA-4 blockade synergizes with tumor-derived granulocyte\u2013macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma","volume":"95","author":"Hurwitz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB14","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4(+) T cells in the antitumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB15","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte\u2013macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB16","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.164.7.3902","article-title":"Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor","volume":"164","author":"Baxevanis","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB17","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.4049\/jimmunol.165.11.6047","article-title":"Tumor-specific CD4+ T cells have a major \u201cpost-licensing\u201d role in CTL mediated anti-tumor immunity","volume":"165","author":"Marzo","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.191.3.541","article-title":"CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes","volume":"191","author":"Lu","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0952-7915(94)90078-7","article-title":"MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy","volume":"6","author":"Topalian","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB20","first-page":"21","article-title":"Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen","volume":"56","author":"Lin","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0952-7915(98)80228-8","article-title":"The role of CD4+ T cell responses in antitumor immunity","volume":"10","author":"Pardoll","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1471-4906(01)01896-8","article-title":"The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity","volume":"22","author":"Wang","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ijc.2910580113","article-title":"Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein\u2013Barr virus-transformed B cells","volume":"58","author":"Topalian","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ijc.10154","article-title":"Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines","volume":"98","author":"Housseau","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB25","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood.V99.9.3319","article-title":"Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells","volume":"99","author":"Bergwelt-Baildon","year":"2002","journal-title":"Blood"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/4716","article-title":"In vivo migration and function of transferred HIV-1-specific cytotoxic T cells","volume":"5","author":"Brodie","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB27","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood.V96.10.3490","article-title":"Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells","volume":"96","author":"Schlienger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4049\/jimmunol.154.2.762","article-title":"Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition","volume":"154","author":"Stevens","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB29","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.159.12.5921","article-title":"Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells","volume":"159","author":"Levine","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB30","doi-asserted-by":"crossref","unstructured":"A.K. Thomas, M.V. Maus, W.S. Shalaby, C.H. June, J.L. Riley, A cell based artificial antigen presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long term growth of CD4 T lymphocytes, Clin. Immunol., in press (2002)","DOI":"10.1006\/clim.2002.5277"},{"key":"10.1016\/S1521-6616(02)00017-7_BIB31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4\u20131BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB32","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1172\/JCI8476","article-title":"MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen","volume":"104","author":"Novak","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S1521-6616(02)00017-7_BIB33","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1128\/MCB.7.12.4472","article-title":"T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression","volume":"7","author":"June","year":"1987","journal-title":"Mol. Cell Biol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661602000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661602000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T21:54:35Z","timestamp":1704750875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661602000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S1521661602000177"],"URL":"https:\/\/doi.org\/10.1016\/s1521-6616(02)00017-7","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}